Discovery of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors

被引：18

作者：

Qian, Yimin ^{[1
]}

Ahmad, Mushtaq ^{[1
]}

Chen, Shaoqing ^{[1
]}

Gillespie, Paul ^{[1
]}

Le, Nam ^{[1
]}

Mennona, Frank ^{[1
]}

Mischke, Steven ^{[1
]}

So, Sung-Sau ^{[1
]}

Wang, Hong ^{[1
]}

Burghardt, Charles ^{[1
]}

Tannu, Shahid ^{[1
]}

Conde-Knape, Karin ^{[1
]}

Kochan, Jarema ^{[1
]}

Bolin, David ^{[1
]}

机构：

[1] Hoffmann La Roche Inc, Dept Discovery Chem & Metab Dis, Nutley, NJ 07110 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 21期

关键词：

Glutamine fructose-6-phosphate amidotransferase (GFAT); Isoquinoline derivatives; Photo cyclization; Enzyme inhibitor; Diabetes target; Oral glucose tolerance test (OGTT); INSULIN-RESISTANCE; GLUTAMINEFRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; PRODUCTS; GLUCOSE; GENE;

D O I：

10.1016/j.bmcl.2011.09.009

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Through high throughput screening and subsequent hit identification and optimization, we synthesized a series of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as the first reported potent and reversible GFAT inhibitors. SAR studies of this class of compounds indicated significant impact on GFAT inhibition potency by substitutions on the A-ring and C-ring. The ketone group was found to be necessary for high potency. Compound 28 (RO0509347) demonstrated potent GFAT inhibition (IC(50) = 1 mu M) with a desirable pharmacokinetic profile in rats, and showed significant efficacy in reducing the glucose excursion in an OGTT test in ob/ob mice. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：6264 / 6269

页数：6

共 50 条

[21] Regulation of glutamine: Fructose-6-phosphate amidotransferase by glucose in rat mesangial cells.
Simmons, S
McClain, D
Cameron, J
Crook, E
FASEB JOURNAL, 1996, 10 (03): : 1179 - 1179
[22] INCREASED SKELETAL-MUSCLE GLUTAMINE - FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE ACTIVITY IN NIDDM
YKIJARVINEN, H
DANIELS, MC
VIRKAMAKI, A
MAKIMATTILA, S
DEFRONZO, RA
MCCLAIN, D
DIABETOLOGIA, 1995, 38 : A152 - A152
[23] Acute and tissue specific regulation of glutamine: Fructose-6-phosphate amidotransferase by insulin in vivo
Rissanen, E
Virkamaki, A
Hamalainen, S
YkiJarvinen, H
DIABETOLOGIA, 1997, 40 : 1116 - 1116
[24] Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM
YkiJarvinen, H
Daniels, MC
Virkamaki, A
Makimattila, S
DeFronzo, RA
McClain, D
DIABETES, 1996, 45 (03) : 302 - 307
[25] Glutamine: Fructose-6-Phosphate amidotransferase activity is increased in adipocytes from obese humans
Bender, BS
Cooksey, RC
Zhang, PL
Klenk, ES
Jones, R
Inman, M
Muse, J
Nachreiner, R
McClain, DA
Considine, RV
DIABETES, 2001, 50 : A413 - A413
[26] Cloning and characterization of mouse glutamine:fructose-6-phosphate amidotransferase 2 gene promoter
Yamazaki, K
Mizui, Y
Oki, T
Okada, M
Tanaka, I
GENE, 2000, 261 (02) : 329 - 336
[27] Induction of macrophage glutamine: Fructose-6-phosphate amidotransferase expression by hypoxia and by picolinic acid
Manzari, B.
Kudlow, J. E.
Fardin, P.
Merello, E.
Ottaviano, C.
Puppo, M.
Eva, A.
Varesio, L.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2007, 20 (01) : 47 - 58
[28] Identification of a novel serine phosphorylation site in human Glutamine:Fructose-6-phosphate amidotransferase isoform 1
Li, Yanyan
Roux, Celine
Lazereg, Sylvie
LeCaer, Jean-Pierre
Laprevote, Olivier
Badet, Bernard
Badet-Denisot, Marie-Ange
BIOCHEMISTRY, 2007, 46 (45) : 13163 - 13169
[29] Presence of glutamine:fructose-6-phosphate amidotransferase for glucosamine-6-phosphate synthesis in endothelial cells: effects of hyperglycaemia and glutamine
G. Wu
T. E. Haynes
W. Yan
C. J. Meininger
Diabetologia, 2001, 44 : 196 - 202
[30] Glutamine fructose-6-phosphate amidotransferase (GFAT) gene expression and activity in patients with type 2 diabetes: Inter-relationships with hyperglycaemia and oxidative stress
Srinivasan, Vedantham
Sandhya, Narasinihan
Sampathkumar, Rangasamy
Farooq, Syed
Mohan, Viswanathan
Balasubramanyam, Muthuswamy
CLINICAL BIOCHEMISTRY, 2007, 40 (13-14) : 952 - 957

← 1 2 3 4 5 →